Phase 3 NEAT clinical trial on track with 32 patients enrolled to date with majority of U.S. and European study sites now ...

The demand for organoids is being driven mainly by an increased preference for personalized medicine, a rising trend of using organoids as alternatives to animal testing, and their expanding ...

In her first Mansion House speech as chancellor, Rachel Reeves is set to announce a series of regulatory changes aimed at reinforcing the UK’s position as a global financial powerhouse.

Discover how to navigate CMC processes effectively in drug development. Learn from industry leaders and ensure your project’s success. From Design Space InPharmatics LLC 13 Nov 2024 ...

There are four stages of osteoarthritis (OA): early, mild, moderate, and severe. You can also be diagnosed with a stage called pre-osteoarthritis. OA is a progressive joint disease caused by cartilage ...

Neurontin (gabapentin), generally prescribed for the treatment of nerve pain, is sometimes used to relieve severe pain caused by knee osteoarthritis (OA). Osteoarthritis, also known, as wear-and-tear ...

Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...

With “Momentum” as the theme of our 2023 Annual Report, learn about the incredible progress being made to support the arthritis community. Alongside patients, volunteers, partners and other ...

What is juvenile idiopathic arthritis? Juvenile idiopathic arthritis (JIA) is a form of arthritis in children. Arthritis causes joint swelling (inflammation) and joint stiffness. JIA is arthritis that ...